• bitcoinBitcoin(BTC)$62,392.00-3.16%
  • ethereumEthereum(ETH)$1,762.97-2.30%
  • tetherTether(USDT)$1.00-0.03%
  • binancecoinBNB(BNB)$577.94-2.26%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.96-0.59%
  • solanaSolana(SOL)$72.88-0.99%
  • tronTRON(TRX)$0.3087460.47%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.010.52%
  • HyperliquidHyperliquid(HYPE)$66.27-3.82%
  • zcashZcash(ZEC)$909.93-2.91%
  • moneroMonero(XMR)$498.80-1.82%
  • dogecoinDogecoin(DOGE)$0.058337-1.76%
  • leo-tokenLEO Token(LEO)$9.28-0.46%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$60.48-2.80%
  • chainlinkChainlink(LINK)$9.00-2.07%
  • cardanoCardano(ADA)$0.150200-2.40%
  • Ethena USDeEthena USDe(USDE)$1.00-0.02%
  • stellarStellar(XLM)$0.136743-1.84%
  • daiDai(DAI)$1.00-0.01%
  • nearNEAR Protocol(NEAR)$3.25-1.53%
  • bitcoin-cashBitcoin Cash(BCH)$206.38-1.63%
  • litecoinLitecoin(LTC)$43.67-2.45%
  • CantonCanton(CC)$0.0815200.53%
  • RainRain(RAIN)$0.004481-7.64%
  • uniswapUniswap(UNI)$5.14-1.41%
  • avalanche-2Avalanche(AVAX)$6.95-2.89%
  • tether-goldTether Gold(XAUT)$3,719.05-3.10%
  • suiSui(SUI)$0.71-2.00%
  • USD1USD1(USD1)$1.00-0.02%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.01-4.42%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • hedera-hashgraphHedera(HBAR)$0.055763-2.04%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.02%
  • BittensorBittensor(TAO)$190.30-1.55%
  • shiba-inuShiba Inu(SHIB)$0.000004-1.96%
  • crypto-com-chainCronos(CRO)$0.042349-3.58%
  • quant-networkQuant(QNT)$149.76-2.11%
  • MemeCoreMemeCore(M)$0.88-1.42%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.20%
  • okbOKB(OKB)$86.25-0.06%
  • Falcon USDFalcon USD(USDF)$1.000.07%
  • pax-goldPAX Gold(PAXG)$3,717.27-3.25%
  • aaveAave(AAVE)$107.54-3.07%
  • United StablesUnited Stables(U)$1.00-0.05%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Drugmakers to raise US prices on 350 medicines despite pressure from President Trump

December 31, 2025
in Business
Reading Time: 3 mins read
A A
Drugmakers to raise US prices on 350 medicines despite pressure from President Trump
ShareShareShareShareShare

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as President Trump pressures them for cuts, according to data provided exclusively by healthcare research firm 3 Axis Advisors.

YOU MAY ALSO LIKE

Two ABC News journos put on paid leave following botched Donald Trump Jr. article: report

Companies are spending Trump’s tariff refunds on bonuses – not reimbursing shoppers: report

The number of price increases for 2026 is up from the same point last year, when drugmakers unveiled plans for raises on more than 250 drugs.

The median of this year’s price hikes is around 4% — in line with 2025.

President Trump has been pressuring drug companies to lower prices in the US. Ron Sachs/CNP / SplashNews.com

The increases do not reflect any rebates to pharmacy benefit managers and other discounts.

Drugmakers also plan to cut the list prices on around nine drugs.

That includes a more than 40% cut for Boehringer Ingelheim’s diabetes drug Jardiance and three related treatments.

Boehringer Ingelheim and Eli Lilly, which sell Jardiance together, did not immediately respond to requests for comment on the reason for the price cuts.

Jardiance is among the 10 drugs for which the U.S. government negotiated a lower price for the Medicare program for people aged 65 and older in 2026.

Under those negotiations, Boehringer and Lilly slashed the Jardiance price by two-thirds.

US patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay in similarly wealthy nations.

The increases on 350 medicines come even as Trump has struck deals with 14 drugmakers on prices of some of their medicines for the government’s Medicaid program for low-income Americans and for cash payers.

US patients currently often pay nearly three times more for medicines than those in other developed nations. Tetra Images/Tetra Images – stock.adobe.com

Pfizer, Sanofi, Boehringer Ingelheim, Novartis and GSK are among those companies and also plan to raise prices on some drugs on Thursday.

“These deals are being announced as transformative when, in fact, they really just nibble around the margins in terms of what is really driving high prices for prescription drugs in the U.S.,” said Dr. Benjamin Rome, a health policy researcher at Brigham and Women’s Hospital in Boston.

Rome said the companies seem to be maximizing prices while negotiating discounts behind the scenes with health and drug insurers and then setting yet another price for direct-to-consumer cash-pay sales.

An HHS spokesman declined to comment.

Pfizer announced the most list price hikes, on around 80 different drugs, including cancer drug Ibrance, migraine pill Nurtec, and COVID treatment Paxlovid, as well as some administered in hospitals such as morphine and hydromorphone.

Pfizer has announced the most list price hikes, on around 80 different drugs. REUTERS

Most of Pfizer’s increases are below 10%, except for a 15% hike of COVID vaccine Comirnaty, while some of its relatively inexpensive hospital drugs saw more than four-fold increases.

Pfizer said in a statement it had adjusted the average list price of its innovative medicines and vaccines for 2026 below the overall rate of inflation.

“The modest increase is necessary to support investments that allow us to continue to discover and deliver new medicines as well as address increased costs throughout our business,” the company said.

Larger U.S. drug price increases were once far more common. 

GSK plans to increase prices on around 20 drugs and vaccines from 2% to 8.9% REUTERS

Drugmakers have scaled them back due to criticism from lawmakers and new government policies, such as penalizing companies that charge Medicare program prices that rise faster than inflation.

European drugmaker GSK plans to increase prices on around 20 drugs and vaccines from 2% to 8.9%. The drugmaker said it is committed to reasonable prices and the hikes are needed to support scientific innovation.

Sanofi and Novartis did not respond to requests for comment.

More price hikes and cuts can be expected in early January, which is historically the biggest month for drugmakers to raise prices.

3 Axis is a consulting firm that works with pharmacist groups, health plans and some pharmaceutical industry-related groups on drug pricing and supply chain issues. It is a related entity to, and shares staff with, drug pricing non-profit 46brooklyn.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Two ABC News journos put on paid leave following botched Donald Trump Jr. article: report
Business

Two ABC News journos put on paid leave following botched Donald Trump Jr. article: report

November 18, 2026
Companies are spending Trump’s tariff refunds on bonuses – not reimbursing shoppers: report
Business

Companies are spending Trump’s tariff refunds on bonuses – not reimbursing shoppers: report

November 18, 2026
Nvidia’s Jensen Huang agrees to testify before Senate, Chairman Tim Scott says
Business

Nvidia’s Jensen Huang agrees to testify before Senate, Chairman Tim Scott says

November 18, 2026
Why it feels like the entire internet is breaking right now and what’s really going on
Business

Why it feels like the entire internet is breaking right now and what’s really going on

November 18, 2026
Next Post
California braces for more storms as atmospheric river brings rain and flooding

California braces for more storms as atmospheric river brings rain and flooding

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Quest Diagnostics reports cyber breach affecting ‘certain patient records’

Quest Diagnostics reports cyber breach affecting ‘certain patient records’

November 17, 2026
DBMF: Insurance For When The 60/40 Falters (NYSEARCA:DBMF)

DBMF: Insurance For When The 60/40 Falters (NYSEARCA:DBMF)

November 17, 2026
Cmpnd Releases dspy-wsp: Weight-Space Programming Comes to DSPy

Cmpnd Releases dspy-wsp: Weight-Space Programming Comes to DSPy

November 14, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!